Abacavir/Lamivudine Lupin Healthcare (Uk)

Abacavir/Lamivudine Lupin Healthcare (UK) is a combination antiretroviral medication used to manage HIV infection. This oral treatment helps control the virus and improve quality of life for those living with HIV.

Abacavir/Lamivudine is primarily used in the treatment of HIV infection. This combination therapy works by reducing the amount of HIV in the body, helping to slow the progression of the disease. It is often prescribed as part of a broader antiretroviral regimen to manage HIV and improve immune function.

Common effects of Abacavir/Lamivudine may include headaches, nausea, fatigue, and dizziness. Some individuals might experience skin rashes or gastrointestinal discomfort. These effects vary and are not experienced by everyone taking the medication.

Abacavir/Lamivudine should be used with caution in individuals with a history of liver or kidney problems. It is important to follow medical advice and report any severe or persistent side effects. Regular monitoring may be required during treatment.

Abacavir/Lamivudine may interact with other medications, including certain antiretrovirals, antibiotics, and medications metabolized by the liver. Alcohol and other substances that affect the liver should be avoided. Always consult a healthcare provider before starting any new medication.